AXA Private Equity has signed a binding agreement with Progressio SGR, on behalf of the Fund Progressio Investimenti II, to sell its majority (88 per cent) stake in Duplomatic Oleodinamica. Based in Parabiago, Milan, Duplomatic Group is a producer of hydraulic valves, pumps and oil-pressure activated systems which are
Law firm Eversheds has advised ECI Partners on the secondary management buy out of premium rail travel company Amber Travel from Primary Capital, valuing the business at over GBP50m. Amber Travel is a leading player in the specialist rail tour industry, offering escorted group holidays to destinations around the
The Scottish Loan Fund (SLF), which is managed by Maven Capital Partners, has invested in three more growth-focused businesses. In the two years since launch the SLF has now committed over GBP28m of funds in 11 Scottish SMEs. Set up to address the market need for finance, funding
Water Street Healthcare Partners, a private equity firm focused exclusively on the healthcare industry, has invested in CCBR-SYNARC. Comprised of two businesses that specialise in outsourced clinical services, CCBR-SYNARC expands Water Street’s global presence in the pharmaceutical services sector. It also marks the healthcare firm’s first investment from its
Rockpool Investments, the private equity investment firm headed by Nicola Horlick, has completed a first close of a planned GBP1.675m investment in Chicago Rib Shack, the fast casual dining restaurant founded and operated by Christian Arden. The EIS-qualifying investment, which was taken up by members of the Rockpool Network
RJD Partners has exchanged contracts to realise its investment in Ipes, one of Europe’s leading providers of fund administration and outsourcing services, in a buyout backed by Silverfleet Capital. The transaction values Ipes at GBP50m, giving a return to RJD of 3x its original investment. Final completion is subject to
Segulah IV has entered into an agreement to sell 100 per cent of the shares in Medstop Group to Oriola-KD. The transaction, which is subject to the approvals of the Swedish Competition Authority (Konkurrensverket) and the Swedish Medical Products Agency (Läkemedelsverket), values the company to SEK1,460m including an estimate
Maven Capital Partners, a private equity and alternative asset manager, has completed the acquisition of Fundamental Tracker Investment Management (FTIM) from City of London Group. The primary business of FTIM is The Munro UK Dividend Fund, a passive tracker OEIC which will be rebranded under the Maven name in
A consortium led by iCON Infrastructure Partners II and including EEA and 2OC has entered into agreements to fund and construct an environmentally friendly 19 MW CHP facility that will provide heat and power under long-term contracts to Thames Water Utilities and National Grid. The facility is located in
GenSight Biologics, a biopharmaceutical company focused on the development of ophthalmic therapeutics using gene therapy, has closed a EUR32m Series A financing. The financing was co-led by Novartis Venture Fund, Abingworth, Versant Ventures and Index Ventures. GenSight will use the funds to develop a gene replacement therapy for
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
